Management of the side-effects of intravenous bisphosphonates: Targeting the serum parathyroid hormone elevation [6]

Annals of Oncology

Volumn 17, Issue 12, 2006, Pages 1854-1855

  Berruti, Alfredo ^a   Tucci, M ^a   Generali, D ^b   Mosca, A ^a   Ardine, M ^c   Vana, F ^a   Dogliotti, L ^a  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

^b CREMONA HOSPITAL   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PARATHYROID HORMONE; VITAMIN D; ZOLEDRONIC ACID;

APOPTOSIS; BONE METASTASIS; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPOCALCEMIA; INTESTINE RESECTION; LETTER; PARATHYROID HORMONE BLOOD LEVEL; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; THYROPARATHYROIDECTOMY; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

DIPHOSPHONATES; HUMANS; HYPOCALCEMIA; PARATHYROID HORMONE;

EID: 33845356069     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl181     Document Type: Letter

References (5)

1. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17: 897-907.
2. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26: 78-l13.
3. McCarty MF. Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypothesis 2000; 54: 475-482.
4. Berruti A, Dogliotti L, Tampellini M et al. Effect of zoledronic acid treatment based on serum parathyroid hormone levels in patients with malignant bone disease. Proc Am Soc Clin Oncol 2006; 495S: Abstr 8610.
5. Garland CF, Garland FC, Gorham ED et al. The role of vitamin D in cancer prevention. Am J Pub Hlth 2006; 96: 252-261.